In 303 UK adults with type 2 diabetes on basal insulin, real-time CGM vs self-monitoring of blood glucose lowered HbA1c at 16 weeks (8.0% vs 8.7%; adjusted difference -0.6), with benefit sustained at 32 weeks (-0.5).
RCTn = 303
Wilmot et al. Continuous glucose monitoring versus self-monitoring of blood glucose in individuals with type 2 diabetes: a randomised, multicentre, open-label, superiority trial